High-throughput mutational screening adds clinically important information in myelodysplastic syndromes and secondary or therapy-related acute myeloid leukemia

oleh: Mohsen Karimi, Christer Nilsson, Marios Dimitriou, Monika Jansson, Hans Matsson, Per Unneberg, Sören Lehmann, Juha Kere, Eva Hellström-Lindberg

Format: Article
Diterbitkan: Ferrata Storti Foundation 2015-06-01

Deskripsi

No description available for this item.